Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination
- PMID: 34114269
- DOI: 10.1002/ana.26144
Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination
Abstract
Although SARS-CoV-2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthesias variant of Guillain-Barré syndrome (GBS) occurring within 3 weeks of vaccination with the Oxford-AstraZeneca SARS-CoV-2 vaccine. This rare neurological syndrome has previously been reported in association with SARS-CoV-2 infection itself. Our cases were given either intravenous immunoglobulin, oral steroids, or no treatment. We suggest vigilance for cases of bifacial weakness with paresthesias variant GBS following vaccination for SARS-CoV-2 and that postvaccination surveillance programs ensure robust data capture of this outcome, to assess for causality. ANN NEUROL 2021;90:315-318.
© 2021 American Neurological Association.
Comment in
-
Guillain-Barré Syndrome in an Australian State Using Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines.Ann Neurol. 2021 Nov;90(5):856-858. doi: 10.1002/ana.26218. Epub 2021 Sep 28. Ann Neurol. 2021. PMID: 34528279 Free PMC article. No abstract available.
Similar articles
-
Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.BMJ Case Rep. 2021 Nov 30;14(11):e246701. doi: 10.1136/bcr-2021-246701. BMJ Case Rep. 2021. PMID: 34848426 Free PMC article.
-
Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.BMJ Case Rep. 2021 Oct 14;14(10):e244527. doi: 10.1136/bcr-2021-244527. BMJ Case Rep. 2021. PMID: 34649856 Free PMC article.
-
Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.Sci Rep. 2024 Aug 13;14(1):18767. doi: 10.1038/s41598-024-66999-7. Sci Rep. 2024. PMID: 39138276 Free PMC article.
-
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?J Neuroimmunol. 2021 Nov 15;360:577719. doi: 10.1016/j.jneuroim.2021.577719. Epub 2021 Sep 17. J Neuroimmunol. 2021. PMID: 34560365 Free PMC article. Review.
-
Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.Clin Neurol Neurosurg. 2024 Mar;238:108183. doi: 10.1016/j.clineuro.2024.108183. Epub 2024 Feb 20. Clin Neurol Neurosurg. 2024. PMID: 38401232 Review.
Cited by
-
A Death for Guillain-Barrè Syndrome After Receiving a COVID-19 Vaccine: A Case Report.Clin Med Insights Case Rep. 2024 Oct 5;17:11795476241274692. doi: 10.1177/11795476241274692. eCollection 2024. Clin Med Insights Case Rep. 2024. PMID: 39377049 Free PMC article.
-
Incidence of Guillain-Barré Syndrome (GBS) after COVID-19 Vaccination: a Systematic Review and Meta-Analysis.Maedica (Bucur). 2024 Jun;19(2):410-416. doi: 10.26574/maedica.2024.19.2.410. Maedica (Bucur). 2024. PMID: 39188850 Free PMC article. Review.
-
Identifying and reducing risks of neurological complications associated with vaccination.Nat Rev Neurol. 2024 Sep;20(9):541-554. doi: 10.1038/s41582-024-01000-7. Epub 2024 Aug 7. Nat Rev Neurol. 2024. PMID: 39112653 Review.
-
Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.Vaccines (Basel). 2024 May 24;12(6):575. doi: 10.3390/vaccines12060575. Vaccines (Basel). 2024. PMID: 38932303 Free PMC article. Review.
-
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224. Pharmacol Res Perspect. 2024. PMID: 38864106 Free PMC article. Review.
References
-
- Possible link between COVID-19 vaccine AstraZeneca and extremely rare, unlikely to occur blood clots. Press release. 2021. Available at https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-p.... Accessed 7 April, 2021.
-
- Susuki K, Koga M, Hirata K, et al. A Guillain-Barré Syndrome variant with prominent facial diplegia. J Neurol 2009;256:1899-1905.
-
- Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 1994;51:671-675.
-
- Goh Y, Beh DLL, Makmur A, et al. Pearls & oy-sters: facial nerve palsy in COVID-19 infection. Neurology 2020;95:364-367.
-
- Uncini A, Vallat JM, Jacobs BC. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry 2020;91:1105-1110.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
